Myriad Genetics (MYGN) Total Debt Growth (1y) (2017 - 2026)
Myriad Genetics (MYGN) Total Debt Growth (1y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 257.85% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 26.24% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 12.18% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 33.69% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | -72.10% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 108.22% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 10.49% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -0.07% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 7.45% |
| 10 | Myriad Genetics | 562.20 Mn | 437.80 Mn | 137.60 Mn | 102.87% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102.87% |
| Dec 31, 2025 | 202.78% |
| Sep 30, 2025 | 206.41% |
| Jun 30, 2025 | 53.09% |
| Mar 31, 2025 | 53.23% |
| Dec 31, 2024 | 2.86% |
| Sep 30, 2024 | 1.30% |
| Jun 30, 2024 | 1.04% |
| Jun 30, 2021 | 3,258.06% |
| Dec 31, 2020 | 6,511.76% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | -8.82% |
| Mar 31, 2020 | -16.22% |
| Dec 31, 2019 | -35.85% |
| Sep 30, 2019 | -37.74% |
| Jun 30, 2019 | -35.85% |
| Mar 31, 2019 | -50.00% |
| Dec 31, 2018 | -92.43% |
| Sep 30, 2018 | -90.19% |
| Jun 30, 2018 | -95.84% |